Immediate Impact
59 standout
Citing Papers
Fluorescent Probes for Disease Diagnosis
2024 Standout
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
2022 Standout
Works of Anne K. Baumgärtner being referenced
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Anne K. Baumgärtner | 223 | 69 | 48 | 191 | 153 | 9 | 433 | |
| Patrícia Moretto | 181 | 81 | 28 | 75 | 58 | 18 | 466 | |
| Carmelina Rodinò | 239 | 106 | 23 | 235 | 59 | 17 | 438 | |
| Joachim Yahalom | 66 | 113 | 45 | 122 | 136 | 12 | 390 | |
| Mary Jones | 128 | 149 | 101 | 85 | 28 | 12 | 423 | |
| Ming‐Shian Lu | 195 | 161 | 9 | 144 | 67 | 9 | 433 | |
| Patrick M. Travis | 228 | 35 | 51 | 343 | 20 | 10 | 472 | |
| Leanne McCulloch | 199 | 25 | 18 | 71 | 20 | 16 | 446 | |
| Garey L. McLellan | 48 | 203 | 148 | 143 | 32 | 13 | 376 | |
| Scott J. Ellner | 77 | 120 | 34 | 97 | 95 | 17 | 398 | |
| Angelika Bezan | 174 | 133 | 18 | 155 | 15 | 16 | 381 |
All Works
Loading papers...